Drug design foundations Flashcards

1
Q

What is the difference between a lead molecule and a candidate drug?

A

A lead molecule is the molecule that acts on a receptor. This receptor can be associated with a disease so this molecule is responsible for the activation of this receptor.
Identification of this lead molecule helps chemists then formulate a drug based on a lead molecule but adapting it to increase selectivity, solubility and reduce toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is IC50?

A

It is how much drug is required to inhibit 50% of the specific enzymatic activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why would you want the IC50 of a drug to be in the nano-molar range?

A

For a drug to be in the nano molar range when it is at a receptor, this means a suitable mass of the drug is consumed initially.
If the IC50 was above the nano molar range the initial mass consumed would be of too high a proportion e.g having bowls of cereal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline the main approaches of drug discovery.

A

Natural products: molecules that are synthesized in plants and bacteria that would have an effect on humans.

Rational approach: modifying naturally existing agonists and antagonists to increase selectivity.

Evolution of existing drugs: Altering them to increase selectivity.

Library of existing drugs: continuation of drug testing of thousands of ‘useless’ drug molecules from university labs.

Serendipity: luck

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some of the disadvantages using natural products to identify a lead compound and synthesize a drug molecule from?

A

In biological systems the lead compound acting on a receptor is highly complex and therefore has a highly complex synthetic route.
Low solubility
Highly degradable bonds- major problem as they candidate drug needs to be stable for shelf life and inside the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the significance of Artemisnin.

A

Artemisnin is an anti malarial drug synthesized from Artemisia annua (a drug used as a traditional Chinese remedy for fever). It is a highly complex structure and very unstable so had to be modified.
Crucially due to high malaria cases being in third world countries it was only during times of war when Westernised countries financially invested into antimalarial.
Today the drug is grown on plantations in Africa so is only available for the native population as a treatment of Malaria- prevents Westernised companies ‘buying’ the drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the significance of venom in the development of Captopril.

A

On attack pit viper’s venom kills by lowering the victim’s blood pressure too low. On realization scientists decided to modify the snake venom specifically the nonapeptide teprotide, reducing toxicity, to a drug that can be used to treat hypertension working on the same enzymes (angiotensin converting enzymes) and therefore become a ACE inhibitor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are sulfonamides and how do they work?

A

Sulfonamides are a group of antibiotics discovered in the 1930s. They work on the biochemical difference between bacteria and humans.
Humans naturally produce folic acid but bacteria synthesises it from p-aminobenzoic acid. During its replication sulfonamides compete for the reaction at the amine group. As a similar molecule it is recognised and incorporated into the molecule so that replication cannot occur at the carboxylic group preventing bacterial growth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are Me too drugs?

A

Essentially they are drugs made by competitive pharmaceutical companies to slightly modify a pre-existing drug for financial profit.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is patent busting and give an example.

A

When a company designs a new drug they patent it which secures profit from the pharmaceutical revenue, the drug cannot be duplicated by a rival company or modified. Patent busting is other companies trying to bust the patent - finding ways to modify the drug in which other companies have not thought of.
An example of this is the development of Ranitidine from Cimetidine, both work as H2 antagonists but Ranitidine has minimal side effects in comparison (not a P450 inhibitor).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Compare structures of Salbutamol and Salmeterol.

A

Quite similar structures, major difference is the long aliphatic chain present in Salmeterol which enables it to bind to the receptor for longer. This therefore is used for patients who are more severely asthmatic and prevents them from having an asthmatic attack over night.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is usually increased when medication is taken at a high dose?

A

The side effects

An example of this was on the brink of WW2 Sulfa-antibiotics were discovered and became crucial for treating minor infections on the frontline. However they were taken at a high dose that most of the patients experienced diuresis and low glucose levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain the process of exploiting the side effects of one drug in order to develop another.

A

The structure of one drug doesn’t just give one activity. Sulfonamides although used to treat bacterial infections gave side effects of diuresis and low glucose levels.

Diuresis is a method of reducing blood pressure. In glaucoma there is a build up of fluid behind the eye, increasing blood pressure. Diuretics work by increasing urine production, reducing fluids levels and therefore pressure. From sulfonamides diuretics such as Clorthizade were developed, still has the same sulfonamide groups.

The drug Tolbutamide was also developed from exploiting the side effects of high dosed Sulfonamides as an effective Diabetic drug to lower blood pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are pro drugs?

A

A pro drug is a drug that is not activated into a pharmaceutically active compound until it is metabolized in the human body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the concepts of in-vitro and in-vivo.

A

For a pharmaceutical drug if a compound is active in vitro it means the drug is active outside of the human body.
For a pharmaceutical drug if a compound is active in vivo it means the drug is active once metabolized by human body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Is prontosil red active in-vitro?

A

In-vitro prontosil red is inactive. However when the drug is reduced by bacteria in the colon which excises the azo bond (-N=N-) it is metabolized and becomes active in-vivo.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is an example of Serendipity?

A

Sildenafil under went clinical trials as it was in vitro able to treat angina and hypertension. However by listening to those who underwent the clinical trials, chemists realised that in-vivo the drug was metabolised and more effective for treating erectile dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the pharmacophore?

A

Once the lead molecule has been identified, the pharmacophore needs to be identified. This is the part of the molecule that is absolutely essential for the activity of the drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Outline the process of identifying the pharmacophore?

A

Of the lead compound, multiple analoges are made. These are essentially slightly different versions of the lead compound (plus or minus a functional group).
Their structure activity relationship is then tested and by comparing them you can identify which parts of the lead compound is essential for activity and this is the pharmacophore.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What occurs after identifying the pharmacophore?

A

This is where there is a transition from chemists to pharmaceutics. The drug is then made into a better pharmaceutically active compound for example functional groups or carbon chains may be added in order to increase hydrophobicity, solubility and to ensure more selective binding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the four guidelines of Lipinski’s rule of five?

A

Molecular weight equal to or <500
Log p equal to or <5
Number of hydrogen bond accepting groups equal to or <10
Number of hydrogen bond donating groups equal to or <5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the problem of only using one company for importing the drug?

A

The company will realise and put up the cost and make it very expensive to import. By using multiple companies they are forced to keep their prices down.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Why would some companies choose to make a new factory per new drug they discover?

A

If they know the profit from the drug in the market will outweigh the cost of building a new factory. An example of this was Taxol.
However most drugs this is not the case so it means that most companies will remain in the field of its expertise.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Outline the key differences between drugs binding to receptors and drugs binding to enzymes.

A

When drugs bind to receptors:
The ligand is structurally unchanged by the binding
The ligand can active or deactivate a mechanism

When drugs bind to enzymes:
Drug is usually chemically changed by binding
Drug normally inhibits the catalyzation of a reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How can drugs work chemically?

A

By neutralisation: antacids neutralise stomach acid, relieving symptoms for acid reflux and heart burn

By adsorption: morphine and caline solutions work in combination to treat diarrhea. Morphine bind to opoid receptors in the gut slowing down gut movements and then caline absorbs excess fluid.

Surfactants: used for premature babies whose lungs haven’t fully developed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What did Crum, Brown and Fraser make the link between?

A

They realised that the chemical composition of a drug is responsible for its function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Which theories were Ehrlich and Ing responsible for?

A

Paul Elrich- realised that some functional groups are directly related to the activity of a drug, they are crucial for their function. The role of a chemists is to modify these functional groups in order to make them potent, selective and safer for optimal pharmaceutical use.

Ing- realised that one functional group can have two opposite effects due to additional interactions. (Idea of agonists and antagonists).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Compare the structures of agonists and antagonists.

A

They have the same functional groups
However antagonists form a larger structure so therefore form more interactions (perhaps causing them to bind for longer) blocking the agonist.

29
Q

What happens when a substrate bind to an enzyme?

A

Induced fit occurs.
The protein structure of the enzyme is able to alter conformation slightly to ensure the strongest binding interactions can occur with the substrate.

30
Q

What happens when an agonist binds to a receptor?

A

When an agonist binds to the receptor, there is a change in conformation of the receptor which activates a second messenger molecule to begin a downstream effect.
The agonist only binds for a millisecond before dissociating and remains unchanged by the binding so can bind to another.

31
Q

Is the protein backbone or residues more important?

A

The residues as these form the interactions with residues on the receptors.

32
Q

When are covalent bonds wanted?

A

Covalent bonds between the drug molecule and enzymes are wanted- these are the strongest interaction and are important to ensure good binding.

Not wanted between the drug molecule and receptors as the agonist needs to dissociate with the receptor so a response can be induced.
If a covalent bond does form- receptor is forced to dissociate from membrane, recycled and new one is formed (a lot of effort so easier to ensure no covalent bonds can form).

33
Q

What are the positive and negatives of ionic bonds in drug molecules?

A

One of the strongest bonds that can form between the drugs and receptors but unlike covalent bonds they can dissociate.
Unless a residue on an amino acid contains a charged functional group at a physiological pH and so would form an ionic bond, you wouldn’t design a drug to have a charge due to the difficulty of ions being able to cross a membrane (unable to pass passively).

34
Q

What are some of the amino acids that would form ionic bonds?

A

Glutamic acid and Aspartic acid both have carboxylic groups form carboxylate ions at a physiological pH (negative charge).
Lysine, Arginine, Histine all contain basic groups and therefore at a physiological pH form positive ions.

35
Q

What does a physiological pH mean?

A

Essentially the pH of the body. Normally around 7.4 so slightly alkaline.

36
Q

Which functional groups on a receptor would an Histidine amino acid interact with?

A

Histidine has a basic functional group in its amino acid structure so is protonated at a physiological pH. This positive charge (ion) would interact with a negatively charged functional group on the receptor (for example a carboxylic acid) forming an ionic bond.

37
Q

How can you distinguish which amino acids would form hydrogen bonds?

A

For a compound to form hydrogen bonds it either needs to contain a Hydrogen bond donor group or a Hydrogen bond acceptor group.

If there is a hydrogen available it can act as a H bond donor.
If it is a basic group (lone pair of electrons available) it can acts a H bond acceptor.

38
Q

How do van der Waals forces form?

A

Van der Waals forces form not between two aliphatic molecules (for example two methyl groups) but instead due to protein folding, molecules can form greasy pockets known as hydrophobic regions (carbon rich areas) which the drugs can fit in to and due to their own hydrophobic regions can form interactions.

39
Q

What are structure activity relationships?

A

It is the relationship between the chemical composition of the drug and its biological activity.

40
Q

What are the steps in developing a drug from the lead compound?

A
  1. Firstly identify the types of interactions that are possible in the lead compound. Look at the functional groups present and then assess going from the strongest (covalent) to the weakest (van der waals) whether they would form these interactions.
  2. Consider how the structure can be simplified. What changes can be made to enhance binding and improve pharmaceutical ability. The changes should be as minimal as possible (molecular weight should stay within a small range).
  3. Make multiple analoges from the lead compound. Each analog should only have one change in comparison to the lead compound. From these anloges a structure activity relationship can be developed.
  4. From the SARs a pharmacophore can be identified which is a region of the compound which is essential for the activity.
41
Q

Why can’t the lead compound can be used as the candidate drug.

A

There are lots of reasons including:
They are not selective, will bind to multiple receptors inducing a vast range of biological response
The bonds might be degradable, if bonds degrade in the body, the drug becomes unstable
It may be toxic
Forms unsuitable interactions (very covalent)
Highly charged molecule, would be unable to cross the membrane
Could be insoluble

42
Q

What happens after the lead compound is simplified?

A

After it is simplified, parts are then added to the molecule by pharmaceutics to improve and optimise its pharmaceutical ability.

43
Q

What are some examples of drug modifications?

A

The three main examples are:

Simple substitutions- add, change, biosteres and isosteres

Altering the 3D shape- could influence the interactions that are able to form

Chain extension

44
Q

Why and how would you modify a quaternary ammonium?

A

At a physiological pH alongside carboxylic acids and protonated amines, the ammonium would be charged forming ionic interactions.
Unless essential in SAR you would want to modify due to inability of ions to cross membranes.

By changing the nitrogen to a carbon, this has minimal effects in terms of molecular weight, structure and shape but no longer charged.

By testing the new modified compound if it is no longer active, reverse modifications to original.
If active still keep modifications.

45
Q

Why are tertiary amines modified into amides?

A

When protonated tertiary amines become positively charged, forming ionic interactions.
By reducing the basicity of the compound into an amide it can no longer form a positive charge (electrons on Nitrogen wrapped up in conjugated system).

46
Q

What is the best functional group a carboxylic acid can be modified into?

A

Again carboxylic acids are deprotonated at a physiological pH so should be modified into ideally an aldehyde or aliphatic alcohol.
Alcohols can be deprotonated but only in very basic conditions (not the physiological pH).
Can be modified into an ester but the change here compared to aldehydes and alcohols is not minimal.

47
Q

Why is it preferred to modify an alcohol into an ether instead of an ester?

A

Changing an alcohol into an ester is quite a significant change in comparison to an ether where just an methyl group is added.
Both abolish the H bond acceptor and reduce the H bond donor.

48
Q

How does reducing a ketone/aldehyde to an alcohol reduce the activity?

A

Reduction to an alcohol doesn’t actually abolish the H bond acceptor activity as the oxygen on the alcohol contains a lone pair. However the shape of the compound is changed. Switching from a planar to tetrahedral molecule, the H bond accepting group is further away from a H bond donating group meaning the likelihood of forming an interaction is reduced.

49
Q

Why would you want to modify an amide functional group?

A

The oxygen in the amide acts as a H bond acceptor and the nitrogen as a H bond donor. Following Lipinski’s rule of 5 you only want 10 or less H bond accepting groups and 5 or less H bond donating groups. If you have lots of amides present, you may want to modify a couple.

50
Q

What are the four possibilities of amide modification?

A

Methylated amide
Amine
Alkene
Ketone

51
Q

Why is a methylated amine the best amide modfication?

A

It requires the least changes (additional of a carbon is a proportionally small molecular weight addition).
It maintains rigidity (double bond remains).
The hydrogen bond donor group is removed. This is good as only 5 groups are allowed for an ideal drug.

52
Q

How can the activity of pyrrole and pyridine groups be tested?

A

Pyrrole has H bond donor activity (can donate the Hydrogen) and by switching it to Furan which has H bond accepting activity, the activity is reversed and it can then be assessed whether the functional group is essential for activity.

Pyridine has H bond accepting activity (has lone pairs available) by switching it to Benzene which has no H bond donor/acceptor activity, it can be assessed if the compound is essential for activity.

53
Q

Why is it essential to modify esters?

A

Contains two oxygen which can acts as H bond acceptors, although the carbonyl oxygen is more likely.
Esters are easily degraded (due to nucleophilic attack of the electron rich carbon) so they can be enzymatically hydrolysed in the body and chemically hydrolysed on storage.

54
Q

Define isosteres and biosteres.

A

Isosteres: atoms/groups that have the same valency and similar chemical and physical properties (all the modifications listed above).

Biosteres: a chemical group that is used to replace another chemical group within the drug without affecting the activity and binding interactions but enhances the pharmaceutical properties (solubility, selectivity, reducing toxicity).

55
Q

Why are using Carbamates beneficial?

A

Carbamates are biosteres of esters. Replacing a carbon with nitrogen has minimal effect on molecular weight however the Nitrogen has a lone pair of electrons which can be donated to the N-C bond (the carbon which is electron deficient). This reduces the carbon’s susceptibility to undergo nucleophilic attack, therefore stabilising the structure.

56
Q

How can aromatic rings that undergo pi pi stacking be modified?

A

By switching the aromatic ring to a non-aromatic one, the availability of pi electrons are reduced and the shape is changed meaning that the pi pi binding interactions are weakened.

57
Q

Why does the stereochemistry of a drug molecule need to be considered?

A

Normally a lead compound will have at least one chiral centre. For each chiral centre, two stereoisomers are produced.
One isomer will have increased activity in comparison to the other due to the spatial arrangement of the atoms which can enhance binding interactions.

58
Q

What are the two types of chirality?

A

Inherent chirality: one isomer has increased activity over the other due to the spatial arrangement of atoms and therefore optimised binding interactions

Introduced chirality: making a lead compound that does not have a chiral centre into containing one (normally by the addition of a methyl group).

59
Q

Is it better for a drug molecules to be rigid or not?

A

Better to be rigid than flexible as it increases selectivity and prevents it binding to multiple receptors (reduces side effects).

60
Q

What are the methods of rigidification?

A

Essentially you want to prevent rotation, this can be done by:
Introducing a ring structure
Using amides, alkenes (only two conformations)
Introducing alkynes (one conformation)
Conformational blocking: where two electron clouds overlap on a ring which prevents rotation (e.g hydrogen and methyl).

61
Q

Which positions on an aromatic ring will stabilize an electron donating substituent?

A

A substituent such as phenol will be stabilised by resonance if a functional group is placed either on the ortho or para directing position.

62
Q

What is the purpose of chain extension?

A

By increasing the length of the aliphatic chain this exploits the hydrophobic pockets within the receptor, increasing the van der waals binding interactions.

Also by adding functional groups this introduces additional additional binding.

63
Q

For which type of drug molecule is chain extension/introducing new functional groups is often used?

A

For antagonists.

This is because they are bigger molecules are require additional binding interactions to prevent the conformational change occurring in the receptor (inhibiting a downstream effect).

64
Q

What are the differences in binding interactions between atropine and bethanechol?

A

Bethanechol developed from acetylcholine is a muscarinic agonist. Atropine is the muscarinic antagonist which has bigger structure and can form more van der waals interactions, pi pi stacking and hydrogen bonding interactions.

65
Q

What happens if an aliphatic chain in the middle of a drug molecule is too long?

A

Sub optimal binding will occur, interactions don’t occur as directly as they could.

66
Q

Define pharmacophore.

A

Outlines the important functional groups that are required for binding and activity and their relative position to each other/space.

67
Q

What do the 3D diagrams of the Pharmacophore demonstrate?

A

The first demonstrates the distance and angles between the functional groups that are required for activity.

The second outlines which different interactions occur.

68
Q

Describe the pharmacophore of tubocarine.

A

Pharmacophore of tubocarine is two charged nitrogen atoms 11.527A apart. Which has meant the natural product (highly complex) can be synthesised into the analogue Decamethonium which is the two nitrogen atoms and substituents joined by an aliphatic chain of 11.527A length.